Treatment
Treatment A clinical trials
We’re tracking 8,312 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT06772623RecruitingPhase 1/Phase 2
Study of telisotuzumab adizutecan plus immunotherapy for advanced lung cancer
This trial tests a new combination treatment for people with advanced non-squamous non-small cell lung cancer who haven't received prior therapy for advanced disease and don't have specific gene changes. The treatment includes an antibody-drug conjugate (telisotuzumab adizutecan) plus an immunotherapy drug (PD-1 checkpoint inhibitor) to see if it helps shrink tumors and improve outcomes.
Phoenix, ArizonaAges 18 years+ - NCT06381661RecruitingPhase 2
Personalized treatment for sepsis in children and adults
This trial is testing several different treatments to find the best one for each person with sepsis. It looks at specific 'treatable traits' like inflammation, blood clotting problems, or immune system issues to match you with the right therapy. The goal is to improve recovery and survival.
DijonAges 9 months+ - NCT07732699RecruitingPhase 4
Comparing antibiotics for children's sinus infections
This study compares different antibiotics for treating sinus infections in children to see which works best. If your child has a sinus infection, this trial could help find the most effective treatment.
Denver, ColoradoAges 2–12 - NCT07532395Recruiting
CrossFit Training to Help Preschoolers With Autism Get School Ready
This study tests whether a special CrossFit-based exercise program can help preschool children with autism spectrum disorder (autism) improve their physical skills, behavior, and readiness for school. The program combines structured fitness activities designed for young children with autism.
Beijing, Beijing MunicipalityAges 3–6 - NCT07777575RecruitingPhase 4
Exercise and medication for weight loss while preserving muscle
This study tests whether a type 2 diabetes medication (tirzepatide) combined with a supervised resistance training (weight lifting) program helps prevent muscle loss while losing weight. You will either receive the medication or a placebo, and all participants will follow a diet and exercise plan.
München, BavariaAges 18–60 - NCT07355062RecruitingPhase 3
Testing Veverimer for metabolic acidosis in kidney disease
This study tests an oral medicine called Veverimer to see if it safely corrects low bicarbonate levels (metabolic acidosis) in people with chronic kidney disease. It might help you feel better and protect your kidneys.
Chula Vista, CaliforniaAges 18 years+ - NCT07472517RecruitingPhase 3
Obrixtamig plus standard therapy for advanced small cell lung cancer
This trial tests whether adding a new drug, obrixtamig, to the usual first treatment for extensive-stage small cell lung cancer can help people live longer or slow the cancer's growth. The usual treatment is a combination of atezolizumab, carboplatin, and etoposide.
Mobile, AlabamaAges 18 years+ - NCT07880977Recruiting
Shenfu injection for preventing ventilator dependence
This trial tests whether a traditional Chinese medicine called Shenfu injection can help people on breathing machines get off them sooner. If you are on a ventilator, this treatment might reduce the chance of becoming dependent on it.
Yiwu, ZhejiangAges 19–75 - NCT01306019RecruitingPhase 1/Phase 2
Gene therapy for severe combined immunodeficiency in older children and adults
This trial tests a one-time gene therapy that aims to fix the genetic problem causing X-linked severe combined immunodeficiency (XSCID). It is for people aged 2 to 50 who lack a matched sibling donor and have persistent immune problems.
Bethesda, MarylandAges 2–50 - NCT07716449RecruitingPhase 3
Immunotherapy combo for stomach or esophagus cancer
This trial tests a new immunotherapy drug (QLS31905) combined with standard chemotherapy for people with advanced stomach or gastroesophageal junction cancer who have not had prior treatment. It aims to see if this new combination works better than the current standard treatment.
BeijingAges 18 years+ - NCT07344779Recruiting
Darolutamide with hormone therapy for advanced prostate cancer
This study looks at how well the drug darolutamide works when combined with hormone therapy, with or without chemotherapy, for men whose prostate cancer has spread. It aims to see how effective this treatment is in everyday medical practice, not just in a research lab.
Many LocationsAges 18 years+ - NCT07304154RecruitingPhase 1
Experimental cell therapy for autoimmune nerve and muscle diseases
This study tests a new treatment called KITE-363 for people with certain autoimmune diseases that have not improved with standard treatments. It aims to see if the therapy is safe and helpful for conditions like multiple sclerosis, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy.
Newport Beach, CaliforniaAges 18–75 - NCT06885034RecruitingPhase 1/Phase 2
Testing a new drug for advanced bowel or pancreatic cancer
This trial is testing an experimental drug (GSK5764227) either alone or with other treatments for people with advanced colon, rectal, or pancreatic cancer that cannot be removed with surgery. The goal is to see if the drug is safe and effective for these cancers.
Los Alamitos, CaliforniaAges 18 years+ - NCT07881016Recruiting
Long-term study of brain and mood in people with mental health conditions
This study follows people with conditions like schizophrenia, bipolar disorder, depression, or autism over time to learn more about these conditions and improve care. Participants will have clinical, biological, and imaging assessments, including MRI scans.
BesançonAges 15–60 - NCT04651673Recruiting
Knee brace program for adults with knee osteoarthritis pain
This trial looks at using a prescribed knee brace to help relieve knee pain and symptoms from knee osteoarthritis. You may be able to join if your knee braces are being provided through participating clinics and you can consent and complete study questionnaires.
Hässleholm, Skåne CountyAges 18–100 - NCT05948566RecruitingPhase 2
Stroke treatment study for patients up to 24 hours after symptoms
This study tests a new drug (TS23) that may help people who had a stroke and can get treatment between 4.5 and 24 hours after symptoms started. The drug aims to improve recovery by targeting the stroke effects, and the study compares the drug with a placebo to see if it works.
Birmingham, AlabamaAges 18 years+ - NCT07048509Recruiting
Exercise and blood vessel health in healthy and prehypertensive adults
This study compares how moderate and high-intensity interval training affect blood vessel function in healthy adults and those with slightly elevated blood pressure (prehypertension). It aims to see which exercise type may improve vascular health.
LjubljanaAges 18–50 - NCT07062965RecruitingPhase 3
PF-07248144 with fulvestrant for HR+ HER2- advanced breast cancer
This trial tests a new study medicine (PF-07248144) combined with fulvestrant in people with a certain type of advanced breast cancer (HR-positive, HER2-negative) that has worsened after previous treatments. It may be an option if you've already tried a CDK4/6 inhibitor and endocrine therapy.
Anchorage, AlaskaAges 18 years+ - NCT06956014RecruitingPhase 3
Testing a new drug for chronic back and leg pain
This trial tests an investigational drug called VER-01 for people with long-term pain from a pinched nerve in the lower back. It aims to see if the drug safely reduces pain and improves daily life.
Mobile, AlabamaAges 18 years+ - NCT07619599RecruitingPhase 1
PET Scan to Track Lung Cancer Treatment Response
This study uses a special PET imaging scan to help doctors see how well pembrolizumab (an immunotherapy drug) is working against advanced non-small cell lung cancer. You'll receive the scan along with your regular pembrolizumab treatment and possible radiation therapy to help measure treatment response.
Duarte, CaliforniaAges 18 years+ - NCT07037004RecruitingPhase 2
Testing a gut health supplement with immunotherapy after kidney cancer surgery
This trial is testing whether adding a gut health supplement (CBM588) to the immunotherapy drug pembrolizumab can help prevent kidney cancer from returning after surgery. It is for people with certain types of kidney cancer who have not had immunotherapy before.
Duarte, CaliforniaAges 18 years+ - NCT07698535RecruitingPhase 2
Blood test to guide early stopping of prostate cancer therapy
This trial uses a blood test to measure tumor DNA and see if men with advanced prostate cancer can safely stop treatment with a drug called 177Lu-PSMA-617 earlier than usual, or switch to chemotherapy. It may help reduce side effects while still controlling the cancer.
Seattle, WashingtonAges 18 years+ - NCT07807995Enrolling by invitationPhase 3
Long-term treatment for IgA nephropathy
This study tests a medication called povetacicept for long-term use in adults with IgA nephropathy, a kidney disease. If you've already completed the earlier study, this trial aims to see how well the drug works over a longer period to help keep your kidneys working longer.
Arvada, ColoradoAges 18 years+ - NCT07326566RecruitingPhase 2
Silevertinib and chemo for a type of glioblastoma
This trial tests a new drug, silevertinib, combined with temozolomide (a chemotherapy) for people with a newly diagnosed glioblastoma that has certain genetic markers. It aims to see if this combination works better than standard treatment for tumors with these specific features.
Birmingham, AlabamaAges 18 years+
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,312 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.